Objective: To test the hypothesis that once-daily treatment with fluticasone propionate is as effective as twice-daily treatment in children with well controlled asthma. Design: Multicentre ...

A total of 34 (19%) patients receiving twice-daily and 26 (17%) patients receiving once-daily fluticasone propionate recorded at least one asthma-related medication during the study. These ...

Flovent, a corticosteroid treatment now sold under its generic name fluticasone propionate, was one of the most commonly prescribed pediatric asthma treatments, in particular because the inhaler ...

Quintupling the ICS dose in children age 5 to 11 who lose asthma control may worsen outcomes in those with a higher socio-economic status.

More information: Chun-Tse Hung et al, Cost-related non-adherence to medications among adults with asthma in the U.S., 2011–2022, Thorax (2024).DOI: 10.1136/thorax-2024-221778 Emily L Graul et ...

Background Uncontrolled asthma is possibly caused by medication non-adherence, and financial hardship can be a major contributor to non-adherence. Since economic conditions and asthma management have ...

Factors that were associated with cost-related medication nonadherence included demographics and comorbidities. (HealthDay News) — For adults with asthma, the prevalence of cost-related ...